Historical Valuation
Immunocore Holdings PLC (IMCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.84 is considered Undervalued compared with the five-year average of -45.77. The fair price of Immunocore Holdings PLC (IMCR) is between 781.45 to 785.35 according to relative valuation methord. Compared to the current price of 33.05 USD , Immunocore Holdings PLC is Undervalued By 95.77%.
Relative Value
Fair Zone
781.45-785.35
Current Price：33.05
95.77%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Immunocore Holdings PLC (IMCR) has a current Price-to-Book (P/B) ratio of 4.30. Compared to its 3-year average P/B ratio of 6.19 , the current P/B ratio is approximately -30.59% higher. Relative to its 5-year average P/B ratio of 6.16, the current P/B ratio is about -30.20% higher. Immunocore Holdings PLC (IMCR) has a Forward Free Cash Flow (FCF) yield of approximately 0.17%. Compared to its 3-year average FCF yield of 0.37%, the current FCF yield is approximately -53.47% lower. Relative to its 5-year average FCF yield of -2.51% , the current FCF yield is about -106.87% lower.
P/B
Median3y
6.19
Median5y
6.16
FCF Yield
Median3y
0.37
Median5y
-2.51
Competitors Valuation Multiple
AI Analysis for IMCR
The average P/S ratio for IMCR competitors is 381.43, providing a benchmark for relative valuation. Immunocore Holdings PLC Corp (IMCR.O) exhibits a P/S ratio of 3.84, which is -98.99% above the industry average. Given its robust revenue growth of 29.22%, this premium appears sustainable.
Performance Decomposition
AI Analysis for IMCR
1Y
3Y
5Y
Market capitalization of IMCR increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IMCR in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is IMCR currently overvalued or undervalued?
Immunocore Holdings PLC (IMCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.84 is considered Undervalued compared with the five-year average of -45.77. The fair price of Immunocore Holdings PLC (IMCR) is between 781.45 to 785.35 according to relative valuation methord. Compared to the current price of 33.05 USD , Immunocore Holdings PLC is Undervalued By 95.77% .
What is Immunocore Holdings PLC (IMCR) fair value?
IMCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Immunocore Holdings PLC (IMCR) is between 781.45 to 785.35 according to relative valuation methord.
How does IMCR's valuation metrics compare to the industry average?
The average P/S ratio for IMCR's competitors is 381.43, providing a benchmark for relative valuation. Immunocore Holdings PLC Corp (IMCR) exhibits a P/S ratio of 3.84, which is -98.99% above the industry average. Given its robust revenue growth of 29.22%, this premium appears sustainable.
What is the current P/B ratio for Immunocore Holdings PLC (IMCR) as of Jan 10 2026?
As of Jan 10 2026, Immunocore Holdings PLC (IMCR) has a P/B ratio of 4.30. This indicates that the market values IMCR at 4.30 times its book value.
What is the current FCF Yield for Immunocore Holdings PLC (IMCR) as of Jan 10 2026?
As of Jan 10 2026, Immunocore Holdings PLC (IMCR) has a FCF Yield of 0.17%. This means that for every dollar of Immunocore Holdings PLC’s market capitalization, the company generates 0.17 cents in free cash flow.
What is the current Forward P/E ratio for Immunocore Holdings PLC (IMCR) as of Jan 10 2026?
As of Jan 10 2026, Immunocore Holdings PLC (IMCR) has a Forward P/E ratio of -69.00. This means the market is willing to pay $-69.00 for every dollar of Immunocore Holdings PLC’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Immunocore Holdings PLC (IMCR) as of Jan 10 2026?
As of Jan 10 2026, Immunocore Holdings PLC (IMCR) has a Forward P/S ratio of 3.84. This means the market is valuing IMCR at $3.84 for every dollar of expected revenue over the next 12 months.